[1]
Rice, Z., Gooderham, M., Lebwohl, M.G., Simpson, E.L. , Boguniewicz, M., Wollenberg, A., Lazariciu, I., Chan, G.L., Alderfer, J. and Watkins, M. 2023. Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s154. DOI:https://doi.org/10.25251/skin.7.supp.154.